Royal Philips launched the latest edition of its advanced data sharing, analytics and visualisation platform, IntelliSpace Portal 8.0, that helps radiologists detect, diagnose and follow-up on treatment of diseases.
The platform, which was introduced at the 2015 Radiological Society of North America annual meeting (RSNA) in Chicago, US, helps to address changing demands in radiology that result from an increasing prevalence of cancer and its economic toll.
It also delivers new applications such as fast 3D quantitative renderings of tumours in a fully integrated oncology suite to improve diagnostic confidence and patient care.
The US Food and Drug Administration (FDA) granted clearance for Siemens Healthcare's Multitom Rax robotic advanced x-ray system.
The new diagnostic imaging system offers a range of examinations in multiple clinical areas, including emergency medicine, pain management and orthopaedics, as well as conventional 2D radiography, fluoroscopy examinations and angiography applications.
Claimed to be the world's first twin robotic x-ray system, the Multitom Rax holds the capability to capture 3D natural weight-bearing images.
The US Food and Drug Administration (FDA) granted clearance for Hitachi Medical Systems America's two new CT models of the Scenaria platform.
The CT models, Scenaria SE 64 and SE 128, feature added workflow speed and ease of use capabilities to facilitate higher daily scanning volumes for CT facilities.
The company said the Scenaria SE models are smart-dose (XR-29) compliant, including lower dose patient safety capabilities.
Dutch biotech firm SkylineDx received CE-IVD Mark approval from the European Competent Authority for its MMprofiler prognostic test to determine the level of risk of a patient with multiple myeloma (MM).
The company is focused on developing and commercialising new gene signature-based tests to accurately determine the type or status of the disease, as well as to predict the patient's response to a specific treatment.
Multiple myeloma is a type of blood cancer, which originates from plasma cells, a type of white blood cell that is made in the bone marrow.
Lightpoint Medical received a €2.4m grant from the European Commission (EC) under the Horizon 2020 European Union Framework programme for Research and Innovation.
The grant will allow the company to conduct a large-scale clinical trial on breast cancer.
The trial is designed to reduce the rate of re-operations in breast cancer, potentially preventing many thousands of women globally from facing additional surgery.
It also offers cost savings to national healthcare systems.
German medical technology firm Xenios received the CE Mark for its i-cor synchronised cardiac assist system for sale in Europe.
i-cor, which is claimed to be the world's first heartbeat-synchronised cardiac assist for cardiogenic shock and high-risk interventions, uses a miniaturised pump to provide physiological beat-to-beat cardiac assistance.
The system is designed to combine myocardial protection with organ perfusion by assisting the weakened heart with synchronised pulses that are superimposed over the patient's weakened heartbeats.
The US Food and Drug Administration (FDA) approved EDDA Technology's new IQQA-Guide, an intra-operative precision 3D navigation system.
IQQA-Guide is designed to provide intra-operative precision 3D navigation for surgical procedures of thoracic, abdominal and pelvic soft organs.
The system, which is part of the IQQA platform and product suite, expands the IQQA precision 3D imaging analytics into the operating room.
Fujifilm Medical Systems USA announced it will launch its next generation automatic positioning digital radiographic x-ray room system, FDR visionary suite.
The system was unveiled at the annual meeting of the Radiological Society of North America (RSNA) in Chicago from 29 November to 4 December.
FDR Visionary Suite was developed to improve imaging workflow and diagnostic capabilities.
It also allows technologists to focus on a patient's position, safety and comfort.